Mapping the PedsQL™ onto the CHU9D: An Assessment of External Validity in a Large Community-Based Sample
- 3 June 2019
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 37 (9) , 1139-1153
Abstract
Mapping algorithms have been indicated as a second-best solution for estimating health state utilities for the calculation of quality-adjusted life-years within cost-utility analysis when no generic preference-based measure is incorporated into the study. However, the predictive performance of these algorithms may be variable and hence it is important to assess their external validity before application in different settings.Keywords
This publication has 44 references indexed in Scilit:
- Measuring and Valuing Health Benefits for Economic Evaluation in Adolescence: An Assessment of the Practicality and Validity of the Child Health Utility 9D in the Australian Adolescent PopulationValue in Health, 2012
- Valuation of the Child Health Utility 9D IndexPharmacoEconomics, 2012
- Challenges in Health State Valuation in Paediatric Economic EvaluationPharmacoEconomics, 2011
- The quality of life and health utility burden of recurrent respiratory papillomatosis in childrenOtolaryngology–Head and Neck Surgery, 2010
- Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritisHealth and Quality of Life Outcomes, 2010
- A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measuresThe European Journal of Health Economics, 2009
- Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Health and Quality of Life Outcomes, 2008
- Pain and depression in caregivers affected their perception of pain in stroke patientsJournal of Clinical Epidemiology, 2007
- Another look at measures of forecast accuracyInternational Journal of Forecasting, 2006
- Evaluating Health-Related Quality-of-Life Studies in Paediatric PopulationsPharmacoEconomics, 2005